Overview

• Former executive Ryan Sloan alleges Verily used protected health information from more than 25,000 Onduo diabetes patients without authorization for research, marketing, press releases, and conferences.
• An amended complaint says an internal probe from January to March 2022 confirmed multiple breaches across 14 HIPAA Business Associate Agreements dating from 2017 to 2021.
• The filing claims Verily delayed required notifications to covered entities and negotiated contract renewals without disclosing recent breaches.
• The complaint describes retaliation, including the August 2022 termination of Onduo’s general counsel Julia Feldman and Sloan’s January 2023 firing while he was on protected leave.
• Organizations named as potentially affected partners include Walgreens Boots Alliance, Highmark Health, Quest Diagnostics, and Delta Air Lines, while Verily denies the allegations and says it will defend itself.